Rigel Pharmaceuticals, Inc

NovaBay Pharmaceuticals is a clinical stage biopharmaceutical company that develops nonantibiotic, antimicrobial products. Its products target the treatment and prevention of a range of infections in hospitals. It has entered into a licensing and research collaboration agreement with an affiliate of Alcon Incorporated for use of the Aganocide compounds for eyes, ears and sinus and in contact lens solutions. Its products include Aganocide, AgaDerm, AgaNase, and NeutroPhase. The company conducts in vitro and in vivo tests on its compounds that kill a range of bacteria, viruses and infection-causing microbes. NovaBay Pharmaceuticals also offers products for ventilator associated pneumonia, central venous catheter infections, and dialysis access associated infections. The company works in partnership with Kinetic Concepts, which is a medical technology company in the United States that provides advanced wound care and therapeutic services.

MicuRx Pharmaceuticals, Inc is a global biopharmaceutical company headquartered in Shanghai, with branches in California, Hong Kong, and Beijing. Founded in 2007, they are committed to discovering, developing, and delivering innovative medicines that address unmet clinical needs, particularly in the field of antibiotic resistance and kidney disease. With a focus on the design, discovery, and development of novel drugs for infectious diseases and unmet medical needs, MicuRx aims to target drug-resistant bacterial infections and provide the next generation of safe and effective antibiotics.Generated from the website